| NCT03121001 | University of Illinois at Chicago | Sickle Cell Disease | 2017-03-20 | PHASE2 |
| NCT00135967 | Radboud University Medical Center|Hoffmann-La Roche | Glomerulonephritis, Membranous | 2002-05 | PHASE2|PHASE3 |
| NCT01413100 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Systemic Scleroderma | 2011-09-15 | PHASE2 |
| NCT05666336 | Fen Li | Systemic Lupus Erythematosus | 2022-12-31 | PHASE4 |
| NCT01626092 | Masonic Cancer Center, University of Minnesota | Lysosomal Storage Disease|Peroxisomal Disorder | 2012-07-11 | NA |
| NCT01093586 | Case Comprehensive Cancer Center | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Erythroleukemia (M6a)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Adult Pure Erythroid Leukemia (M6b)|B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Burkitt Lymphoma|Childhood Acute Erythroleukemia (M6)|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Juvenile Myelomonocytic Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Prolymphocytic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Secondary Myelofibrosis|Splenic Marginal Zone Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage II Chronic Lymphocytic Leukemia|Stage III Chronic Lymphocytic Leukemia|Stage IV Chronic Lymphocytic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia|T-cell Large Granular Lymphocyte Leukemia|Waldenstrom Macroglobulinemia | 2007-09 | PHASE2 |
| NCT06365437 | ITB-Med LLC | Kidney Transplantation | 2021-06-06 | PHASE2 |
| NCT00545402 | Hoffmann-La Roche | Liver Transplantation | 2007-11 | PHASE4 |
| NCT01350245 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Acute Myeloid Leukemia|Myelodysplastic Syndromes|Biphenotypic Leukemia|Acute Lymphocytic Leukemia|Chronic Myeloid Leukemia|Chronic Lymphocytic Leukemia|Plasma Cell Neoplasms|Lymphoma|Hodgkin´s Disease|Aplastic Anemia | 2010-07 | PHASE2 |
| NCT01109498 | Amsterdam Molecular Therapeutics|International Antiviral Therapy Evaluation Center | Familial Lipoprotein Lipase Deficiency | 2007-08 | PHASE2|PHASE3 |
| NCT00121784 | Hoffmann-La Roche | Heart Transplantation | 2005-10 | PHASE4 |
| NCT00723099 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Chronic Myelogenous Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Indolent Non-Hodgkin Lymphoma|Lymphoma|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Recurrent Chronic Lymphocytic Leukemia|Recurrent Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Recurrent T-Cell Non-Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia|Refractory Follicular Lymphoma|Refractory Hodgkin Lymphoma|Refractory Lymphoplasmacytic Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Small Lymphocytic Lymphoma|T-Cell Non-Hodgkin Lymphoma | 2008-06-25 | PHASE2 |
| NCT00431119 | University Hospital Muenster|Hoffmann-La Roche | Bullous Pemphigoid | 1997-10 | PHASE2 |
| NCT01670565 | Hospital for Special Surgery, New York|Human Genome Sciences Inc. | Systemic Sclerosis | 2012-08 | PHASE2 |
| NCT00239005 | Novartis Pharmaceuticals | Renal Transplant | 2005-09 | PHASE4 |
| NCT02936505 | Vastra Gotaland Region|Oslo University Hospital|Helsinki University Central Hospital|Skane University Hospital|Copenhagen University Hospital, Denmark | Lung Transplantation|Allografts | 2016-10-12 | NA |
| NCT04521946 | M.D. Anderson Cancer Center | Anaplastic Ependymoma|Atypical Teratoid+Rhabdoid Tumor|Central Nervous System Germ Cell Tumor|Choroid Plexus Carcinoma|Intracranial Myeloid Sarcoma|Malignant Brain Neoplasm|Malignant Glioma|Medulloblastoma|Primitive Neuroectodermal Tumor|Recurrent Anaplastic Ependymoma|Recurrent Atypical Teratoid+Rhabdoid Tumor|Recurrent Malignant Brain Neoplasm|Recurrent Malignant Glioma|Recurrent Medulloblastoma|Recurrent Primitive Neuroectodermal Tumor | 2021-01-14 | PHASE1 |
| NCT00387959 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma | 2006-07 | PHASE2 |
| NCT01619761 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|ISS Stage II Plasma Cell Myeloma|ISS Stage III Plasma Cell Myeloma|Myelodysplastic Syndrome|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|Secondary Acute Myeloid Leukemia|Therapy-Related Acute Myeloid Leukemia|Therapy-Related Myelodysplastic Syndrome | 2013-05-03 | PHASE1 |
| NCT01842269 | Chong Kun Dang Pharmaceutical | Kidney Transplantation | 2013-01 | PHASE4 |
| NCT06682169 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Graft-versus-host Disease | 2024-11-20 | PHASE3 |
| NCT05457556 | Children´s Oncology Group | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome | 2023-03-15 | PHASE3 |
| NCT01810588 | Weill Medical College of Cornell University | Hematologic Malignancies | 2012-10-16 | PHASE2 |
| NCT07162038 | National Cancer Institute (NCI) | Hematologic Malignancies|Hematologic Neoplasms | 2025-11-14 | PHASE1 |
| NCT05101447 | Children´s Hospital Medical Center, Cincinnati | Lupus Nephritis | 2023-07 | PHASE2 |
| NCT05538208 | Children´s Hospital Medical Center, Cincinnati|Genentech, Inc.|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Lupus Nephritis | 2024-06-07 | PHASE2 |
| NCT03128359 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Leukemia|Chronic Lymphocytic Leukemia+Small Lymphocytic Lymphoma|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Diffuse Large B-Cell Lymphoma|Follicular Lymphoma|Graft Versus Host Disease|Hodgkin Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma|Secondary Myelodysplastic Syndrome | 2017-05-30 | PHASE2 |
| NCT00309842 | Masonic Cancer Center, University of Minnesota | Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelofibrosis|MDS|Refractory Anemia|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Non-Hodgkin´s Lymphoma|Leukemia|Lymphoma|Multiple Myeloma|Myelodysplastic Syndromes | 2005-07-28 | PHASE2 |
| NCT03734601 | Stanford University | Acute Myeloid Leukemia|Myelodysplastic Syndromes|Myeloproliferative Disorder|Chronic Lymphocytic Leukemia|B-cell Lymphoma|T-cell Lymphoma|Non Hodgkin Lymphoma|Hodgkin Lymphoma|Chronic Myelomonocytic Leukemia | 2018-11-05 | PHASE2 |
| NCT00333437 | University of California, San Francisco|Roche Pharma AG | Scleroderma, Systemic | 2006-05 | NA |
| NCT00057954 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Lymphoma | 2005-11-09 | PHASE2 |
| NCT02793544 | Center for International Blood and Marrow Transplant Research|National Marrow Donor Program | Myelodysplastic Syndrome (MDS)|Chronic Lymphocytic Leukemia (CLL)|Chemotherapy-sensitive Lymphoma|Acute Lymphoblastic Leukemia (ALL)+T Lymphoblastic Lymphoma|Acute Myelogenous Leukemia (AML)|Acute Biphenotypic Leukemia (ABL)|Acute Undifferentiated Leukemia (AUL) | 2016-12 | PHASE2 |
| NCT00038272 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | | PHASE2 |
| NCT00078858 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Childhood Renal Cell Carcinoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Clear Cell Renal Cell Carcinoma|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Juvenile Myelomonocytic Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Renal Cell Cancer|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia+Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage II Adult T-cell Leukemia+Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Renal Cell Cancer|T-cell Large Granular Lymphocyte Leukemia|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies|Waldenstr?m Macroglobulinemia | 2003-09 | PHASE1|PHASE2 |
| NCT04702256 | Assistance Publique - H?pitaux de Paris|Roche Pharma AG | Lupus Nephritis|Systemic Lupus Erythematosus (SLE) | 2021-12-09 | PHASE3 |
| NCT01283841 | Dr. Reddy´s Laboratories Limited | Fasting | 2007-11 | PHASE1 |
| NCT00656266 | Baylor College of Medicine | End-stage Liver Disease|Renal Insufficiency|Renal Failure | 2004-11 | PHASE4 |
| NCT05327023 | National Cancer Institute (NCI) | Hematologic Neoplasms | 2022-05-23 | PHASE1|PHASE2 |
| NCT01043640 | Masonic Cancer Center, University of Minnesota | Mucopolysaccharidosis|Hurler Syndrome|Hunter Syndrome|Maroteaux-Lamy Syndrome|Sly Syndrome|Alpha Mannosidosis|Fucosidosis|Aspartylglucosaminuria|Adrenoleukodystrophy (ALD)|Krabbe Disease|Metachromatic Leukodystrophy (MLD)|Sphingolipidoses|Peroxisomal Disorders | 2009-12 | PHASE2 |
| NCT04205240 | Srinivas Devarakonda | Recurrent Plasma Cell Myeloma | 2020-12-22 | PHASE2 |
| NCT06807606 | M.D. Anderson Cancer Center | Hematologic Malignancies | 2025-03-03 | PHASE2 |
| NCT00317785 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Myelodysplastic Syndromes | 2005-05 | PHASE2 |
| NCT00988715 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myelomonocytic Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Cytopenia With Multilineage Dysplasia|Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts|Secondary Acute Myeloid Leukemia | 2010-04-21 | PHASE1 |
| NCT01801280 | Klemens Budde|Novartis Pharmaceuticals | Transplantation|Immunosuppression|Drug Interaction | 2012-01 | PHASE4 |
| NCT03842696 | University of Michigan Rogel Cancer Center|National Institutes of Health (NIH)|National Center for Advancing Translational Sciences (NCATS) | Hematologic Diseases|Acute Leukemia in Remission|Chronic Myelogenous Leukemia - Chronic Phase|Chronic Myelogenous Leukemia, Accelerated Phase|Chronic Myelogenous Leukemia, Blastic Phase|Myelodysplastic Syndromes|Mantle Cell Lymphoma|Follicular Lymphoma|Diffuse Large B Cell Lymphoma|Non Hodgkin Lymphoma|Graft Vs Host Disease|Graft-versus-host-disease | 2020-02-04 | PHASE1|PHASE2 |
| NCT00035555 | Bristol-Myers Squibb | Graft Rejection|Kidney Transplantation|Renal Transplantation | 2001-03 | PHASE2 |
| NCT02188719 | National Institute of Allergy and Infectious Diseases (NIAID)|Rho Federal Systems Division, Inc. | Liver Transplantation | 2014-12-17 | PHASE1 |
| NCT00185692 | Stanford University | Blood Cancer|Leukemia|Graft Versus Host Disease|Malignancy|CLL|NHL|Hodgkin´s Disease|MDS | 2000-08 | PHASE2 |
| NCT03088709 | Loyola University | Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome|Non-hodgkin Lymphoma|Chronic Lymphocytic Leukemia | 2017-01-18 | PHASE2 |
| NCT00683930 | Hoffmann-La Roche|Aspreva Pharmaceuticals | Pemphigus Vulgaris (PV) | 2004-05 | PHASE3 |
| NCT02918292 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Blood and Marrow Transplant Clinical Trials Network|National Marrow Donor Program | Severe Aplastic Anemia | 2017-07-03 | PHASE2 |
| NCT01304836 | Astellas Pharma Inc | Kidney Transplantation | 2011-01-22 | PHASE4 |
| NCT04868786 | Seoul National University Hospital|National Institute of Food and Drug Safety Evaluation (Republic of Korea) | Hematopoietic Stem Cell Transplantation | 2020-10-26 | PHASE1 |
| NCT00763490 | University of Michigan Rogel Cancer Center|Otsuka Pharmaceutical Development & Commercialization, Inc. | Hematological Malignancies | 2008-12 | PHASE2 |
| NCT05306873 | National Institute of Allergy and Infectious Diseases (NIAID) | Systemic Lupus Erythematosus | 2022-11-30 | PHASE2 |
| NCT03292861 | Cedars-Sinai Medical Center|Genzyme, a Sanofi Company | Heart Transplantation | 2018-09-13 | PHASE2 |
| NCT00305682 | Masonic Cancer Center, University of Minnesota | Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes | 2005-06 | PHASE2 |
| NCT03920059 | Chulalongkorn University|Berlin Pharmaceutical Industry | Lupus Nephritis | 2019-08-20 | PHASE4 |
| NCT00544115 | City of Hope Medical Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Precancerous+Nonmalignant Condition | 2001-10-16 | PHASE2 |
| NCT00193635 | Northwell Health|Hoffmann-La Roche|University of Medicine and Dentistry of New Jersey|New York Presbyterian Hospital | Congenital Urological Abnormalities | 2002-03 | PHASE1 |
| NCT00693524 | Astellas Pharma Inc | Liver Transplantation | 2002-11 | PHASE2 |
| NCT01487577 | University of Pittsburgh | Allogeneic Blood and Marrow Transplantation (BMT)|Graft Versus Host Disease | 2010-06 | PHASE2 |
| NCT01701986 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Hematopoietic Cell Transplantation Recipient|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Hodgkin Lymphoma|Refractory T-Cell Non-Hodgkin Lymphoma | 2012-10-25 | PHASE1|PHASE2 |
| NCT02432339 | Augusta University | Psychological Stress|Hypertension, Renal | 2014-04-22 | PHASE1|PHASE2 |
| NCT01729494 | University of Cincinnati | Renal Transplantation | 2012-09 | PHASE4 |
| NCT00166829 | National Taiwan University Hospital | Kidney Transplantation | 2004-05 | PHASE4 |
| NCT02953873 | Medical University of South Carolina|Astellas Pharma Inc | Immunosuppression | 2017-05-05 | PHASE4 |
| NCT00133172 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Kidney Transplantation | 2005-07 | PHASE4 |
| NCT03171831 | First Affiliated Hospital of Guangxi Medical University | Thalassemia Major | 2017-04-01 | PHASE4 |
| NCT00214266 | University of Wisconsin, Madison | Renal Transplantation | 2005-01 | PHASE2 |
| NCT00934791 | Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer | Polycystic Liver Disease | 2009-02 | NA |
| NCT04402580 | Istituto Giannina Gaslini|Bambino Gesù Hospital and Research Institute | Nephrotic Syndrome Steroid-Dependent | 2019-07-01 | PHASE2 |
| NCT00118742 | Hoffmann-La Roche | Liver Transplantation | 2005-08 | PHASE4 |
| NCT00533442 | University of Miami|Astellas Pharma Inc | Type 1 Diabetes | 2000-09 | PHASE2 |
| NCT04039373 | Bristol-Myers Squibb | Healthy Participants | 2019-07-22 | PHASE1 |
| NCT00686556 | Masonic Cancer Center, University of Minnesota | Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Multiple Myeloma | 2012-08 | PHASE1 |
| NCT01135329 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Lymphoma|Leukemia|Myelodysplastic Syndrome | 2010-08 | PHASE2 |
| NCT01807611 | St. Jude Children´s Research Hospital|Assisi Foundation | Leukemia|Lymphoma | 2013-05-16 | PHASE2 |
| NCT01364987 | Astellas Pharma Inc | Healthy Subjects|Drug Interactions|Pharmacokinetics of ASP015K | 2009-05 | PHASE1 |
| NCT01824693 | Children´s Oncology Group|National Cancer Institute (NCI) | Juvenile Myelomonocytic Leukemia | 2013-06-24 | PHASE2 |
| NCT06996119 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia|Graft Versus Host Disease|Myelodysplastic Syndrome | 2026-05-25 | PHASE1 |
| NCT05807932 | Heinrich-Heine University, Duesseldorf|Koordinierungszentrum für Klinische Studien - Duesseldorf | Myelodysplastic Syndromes|Secondary Acute Myeloid Leukemia|Chronic Myelomonocytic Leukemia | 2023-06-26 | PHASE1|PHASE2 |
| NCT00003145 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase of Disease|Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase of Disease|Recurrent Disease | 1997-08 | PHASE2 |
| NCT02808065 | Seoul National University Hospital|Ministry of Food and Drug Safety, Korea | Kidney Transplantation | 2016-05 | |
| NCT00374647 | University of Cincinnati | Primary Renal Allograft | 2005-03 | PHASE4 |
| NCT00589316 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|CD45-Positive Neoplastic Cells Present|Chronic Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndrome|Refractory Anemia With Excess Blasts|Refractory Anemia With Ring Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts | 2007-10-05 | PHASE1 |
| NCT00429143 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematologic Malignancies | 2006-01 | PHASE1|PHASE2 |
| NCT00006233 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Melanoma (Skin) | 2000-01 | PHASE2 |
| NCT00187915 | University of Florida|Hoffmann-La Roche | Transplant, Kidney | 2003-07 | NA |
| NCT02563782 | Astellas Institute for Regenerative Medicine | Age-Related Macular Degeneration | 2015-08-24 | PHASE2 |
| NCT03828682 | Simon Tremblay, PharmD, PhD|Veloxis Pharmaceuticals | Kidney Transplantation|Immunosuppression | 2019-06-21 | PHASE4 |
| NCT05495893 | Second Xiangya Hospital of Central South University|Peking Union Medical College Hospital|Children´s Hospital of Chongqing Medical University|Beijing Children´s Hospital|Jiangxi Province Children´s Hospital|The Affiliated Hospital of Qingdao University|Shenzhen Children´s Hospital|The First Affiliated Hospital of Zhengzhou University|The Children´s Hospital of Zhejiang University School of Medicine|The Second Hospital of Hebei Medical University | Mycophenolate Mofetil|Cyclophosphamide|Lupus Nephritis | 2022-07-25 | PHASE4 |
| NCT00140543 | EUROSPK Study Group|Fujisawa GmbH|Hoffmann-La Roche|Wyeth is now a wholly owned subsidiary of Pfizer|Neovii Biotech|Genzyme, a Sanofi Company | Diabetes Mellitus, Type 1|Diabetic Nephropathy | 2002-02 | PHASE3 |
| NCT01080417 | Panacea Biotec Ltd | Healthy Volunteers | 2008-06 | NA |
| NCT02554955 | Hoffmann-La Roche | Heart Transplantation | 2004-02 | PHASE4 |
| NCT01016626 | Chong Kun Dang Pharmaceutical | Healthy | 2009-07 | PHASE1 |
| NCT00008450 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Adenosine Deaminase Deficiency|Autosomal Recessive Disorder|Immune System Disorder|Purine-Nucleoside Phosphorylase Deficiency|Severe Combined Immunodeficiency|Severe Combined Immunodeficiency With Absence of T and B Cells|X-Linked Severe Combined Immunodeficiency | 1997-08-11 | PHASE1 |
| NCT04895423 | National Medical Research Center for Children´s Health, Russian Federation | Atopic Dermatitis | 2021-11-25 | PHASE4 |
| NCT02707393 | St. Anna Kinderkrebsforschung | Chronic Myeloid Leukemia | 2009-04-30 | PHASE2|PHASE3 |
| NCT02864706 | Novartis Pharmaceuticals | Heart Transplantation | 2016-01-18 | PHASE4 |
| NCT00206076 | Albert Einstein Healthcare Network|Hoffmann-La Roche | Liver Disease | 2006-08 | PHASE4 |
| NCT06615050 | Incyte Corporation|Blood and Marrow Transplant Clinical Trials Network|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Graft-versus-host Disease (GVHD) | 2025-04-02 | PHASE3 |
| NCT02333162 | University of Chicago|National Cancer Institute (NCI) | Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Hematologic Malignancy | 2014-12-05 | PHASE1 |
| NCT06068179 | The First Affiliated Hospital of Xiamen University | Graves´ Disease | 2023-10-16 | PHASE2|PHASE3 |
| NCT04022239 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Hematopoietic and Lymphoid System Neoplasm | 2020-03-13 | PHASE1|PHASE2 |
| NCT06799195 | University of Nebraska | Hematological Malignancies|Graft-versus-Host Disease (GVHD) | 2025-06-23 | PHASE2 |
| NCT00044954 | University of Texas Southwestern Medical Center | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1999-11 | PHASE2 |
| NCT02582775 | Masonic Cancer Center, University of Minnesota | Epidermolysis Bullosa | 2016-03 | PHASE2 |
| NCT00451867 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Interstitial Cystitis|Painful Bladder Syndrome | 2007-03 | PHASE3 |
| NCT01898377 | Seoul National University Hospital | Chronic Graft-versus-host Disease | 2013-08 | PHASE2 |
| NCT05057481 | Assiut University | Autoimmune Hemolytic Anemia|Systemic Lupus Erythematosus | 2021-09-15 | PHASE3 |
| NCT04933292 | Xiaoli Fan | Autoimmune Hepatitis|Primary Biliary Cirrhosis | 2021-06-16 | PHASE4 |
| NCT00566696 | St. Jude Children´s Research Hospital | Leukemia, Acute Lymphocytic (ALL)|Leukemia, Myeloid, Acute(AML)|Leukemia, Myeloid, Chronic(CML)|Juvenile Myelomonocytic Leukemia (JMML)|Hemoglobinuria, Paroxysmal Nocturnal (PNH)|Hodgkin Lymphoma|Lymphoma, Non-Hodgkin (NHL)|Myelodysplastic Syndrome (MDS) | 2007-12-14 | PHASE2 |
| NCT00096096 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2004-08 | PHASE2 |
| NCT00136903 | Mesoblast, Inc. | Graft Vs Host Disease | 2005-04-27 | PHASE2 |
| NCT04473924 | University of California, San Francisco | Infection|Transplant;Failure,Kidney | 2022-07 | PHASE2 |
| NCT01742624 | Astellas Pharma Korea, Inc. | de Novo Kidney Transplantation | 2012-04 | PHASE4 |
| NCT05907746 | National Cancer Institute (NCI) | GATA2|Immunodeficiency | 2023-11-29 | PHASE2 |
| NCT03492255 | University of Sao Paulo General Hospital|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Systemic Lupus Erythematosus (SLE) | 2018-04-12 | NA |
| NCT04903054 | National Institute of Allergy and Infectious Diseases (NIAID)|Bristol-Myers Squibb|PPD Development, LP | Kidney Transplantation|Renal Transplant Recipients | 2022-01-10 | PHASE2 |
| NCT03959241 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI)|National Marrow Donor Program | Acute Leukemia|Chronic Myelogenous Leukemia (CML)|Myelodysplasia|Lymphoma | 2019-06-25 | PHASE3 |
| NCT00008307 | Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1998-04 | PHASE2 |
| NCT00371319 | Tuen Mun Hospital | Lupus Nephritis | 2005-09 | PHASE4 |
| NCT00112593 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Aggressive NK-cell Leukemia|AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Diffuse Small Cleaved Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Lymphoblastic Lymphoma|AIDS-related Peripheral+Systemic Lymphoma|AIDS-related Primary CNS Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Essential Thrombocythemia|Extramedullary Plasmacytoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|HIV Infection|HIV-associated Hodgkin Lymphoma|Intraocular Lymphoma|Isolated Plasmacytoma of Bone|Juvenile Myelomonocytic Leukemia|Mast Cell Leukemia|Meningeal Chronic Myelogenous Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Myeloid+NK-cell Acute Leukemia|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Polycythemia Vera|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Central Nervous System Lymphoma|Primary Myelofibrosis|Primary Systemic Amyloidosis|Progressive Hairy Cell Leukemia, Initial Treatment|Prolymphocytic Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage 0 Chronic Lymphocytic Leukemia|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia+Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Multiple Myeloma|Stage I Small Lymphocytic Lymphoma|Stage IA Mycosis Fungoides+Sezary Syndrome|Stage IB Mycosis Fungoides+Sezary Syndrome|Stage II Adult Hodgkin Lymphoma|Stage II Adult T-cell Leukemia+Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Hodgkin Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Multiple Myeloma|Stage IIA Mycosis Fungoides+Sezary Syndrome|Stage IIB Mycosis Fungoides+Sezary Syndrome|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Small Lymphocytic Lymphoma|Stage IIIA Mycosis Fungoides+Sezary Syndrome|Stage IIIB Mycosis Fungoides+Sezary Syndrome|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Hodgkin Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Stage IVA Mycosis Fungoides+Sezary Syndrome|Stage IVB Mycosis Fungoides+Sezary Syndrome|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific|Waldenstr?m Macroglobulinemia | 1999-11 | NA |
| NCT05221411 | Leiden University Medical Center | Autoimmune Hepatitis | 2022-01-19 | PHASE4 |
| NCT00048165 | Hoffmann-La Roche | Heart Transplantation | 1999-08 | PHASE4 |
| NCT00539838 | Genentech, Inc.|Roche Pharma AG | Systemic Lupus Erythematosus | 2007-12-19 | PHASE3 |
| NCT00658333 | Novartis Pharmaceuticals | Renal Transplantation | 2008-03 | PHASE4 |
| NCT05237323 | I.M. Sechenov First Moscow State Medical University | Lymphocytic Myocarditis (Disorder)|Heart Failure|Dilated Cardiomyopathy|Cardiomyopathies|Sudden Cardiac Death | 2020-10-01 | PHASE3 |
| NCT01690520 | Nohla Therapeutics, Inc.|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome | 2012-12-11 | PHASE2 |
| NCT00789776 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|The Wayne D. Kuni and Joan E. Kuni Foundation | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Diffuse Large B-Cell Lymphoma|Previously Treated Myelodysplastic Syndrome|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Indolent Adult Non-Hodgkin Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Small Lymphocytic Lymphoma|Waldenstrom Macroglobulinemia | 2008-10-13 | PHASE1|PHASE2 |
| NCT01790594 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation|Rho Federal Systems Division, Inc.|Bristol-Myers Squibb | Simultaneous Kidney and Pancreas Transplantation | 2013-02 | PHASE2 |
| NCT03032783 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematopoietic and Lymphoid Cell Neoplasm | 2017-01-31 | PHASE2 |
| NCT04477629 | NYU Langone Health|Bristol-Myers Squibb | Heart Transplantation | 2020-08-06 | PHASE2 |
| NCT00959231 | Cancer Research UK | Hematopoietic+Lymphoid Cancer | 2009-01 | PHASE2 |
| NCT04207177 | Oslo University Hospital | Kidney Transplant; Complications|Immune Suppression | 2019-10-30 | PHASE4 |
| NCT07566377 | Memorial Sloan Kettering Cancer Center | Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Non-hodgkin Lymphoma|Hodgkin Lymphoma|Leukemia|Lymphoma|Graft-versus-host Disease | 2026-04-28 | PHASE2 |
| NCT00547196 | City of Hope Medical Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Myelodysplastic Syndromes | 2005-08-16 | NA |
| NCT07548983 | OHSU Knight Cancer Institute|Incyte Corporation|Oregon Health and Science University | Acute Myeloid Leukemia | 2026-05-20 | PHASE1 |
| NCT00245037 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms|Precancerous Condition | 2005-06 | PHASE1|PHASE2 |
| NCT01309022 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Diabetes Mellitus, Type 1 | | |
| NCT00064701 | Astellas Pharma Inc | Kidney Transplantation | 2003-06 | PHASE3 |
| NCT00282412 | Northwestern University | Rheumatoid Arthritis | 2002-09 | PHASE1 |
| NCT02221583 | University of Cincinnati|Astellas Pharma Inc | End Stage Renal Disease | 2014-05 | PHASE4 |
| NCT00089141 | Martin, Paul|National Cancer Institute (NCI) | Cancer | 2004-05 | PHASE3 |
| NCT03099122 | Sanofi | End-stage Renal Disease | 2017-08-16 | PHASE4 |
| NCT00571662 | University of Nebraska|Astex Pharmaceuticals, Inc. | Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Myelodysplastic Syndromes|Multiple Myeloma|Non-Hodgkins Lymphoma|Hodgkins Disease|Peripheral T-cell Lymphoma | 2000-12-08 | PHASE2 |
| NCT00891306 | Amsterdam Molecular Therapeutics|The Clinical Trial Company | Familial Lipoprotein Lipase Deficiency | 2009-02 | PHASE2|PHASE3 |
| NCT00134004 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2004-10 | PHASE2 |
| NCT00404833 | Hospital Authority, Hong Kong|The University of Hong Kong | Glomerulonephritis, Membranous|Glomerulosclerosis, Focal | 2003-01 | PHASE3 |
| NCT00301600 | Nanjing University School of Medicine | IGA Nephropathy | 2003-01 | NA |
| NCT00027820 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndrome|Childhood Renal Cell Carcinoma|Chronic Myelomonocytic Leukemia|Clear Cell Renal Cell Carcinoma|de Novo Myelodysplastic Syndrome|Metastatic Renal Cell Cancer|Previously Treated Myelodysplastic Syndrome|Progression of Multiple Myeloma or Plasma Cell Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult Non-Hodgkin Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Non-Hodgkin Lymphoma|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Renal Medullary Carcinoma|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia | 2001-08 | PHASE1|PHASE2 |
| NCT00618527 | Aaron Boster|EMD Serono|Pfizer | Multiple Sclerosis | 2006-08 | EARLY_PHASE1 |
| NCT00717379 | Astellas Pharma Inc | Kidney Transplantation|Kidney Failure, Chronic|Renal Insufficiency, Chronic | 2007-05 | PHASE4 |
| NCT00695344 | Fundacion Investigacion y Desarrollo | Cardiac Transplant | 2006-01 | PHASE4 |
| NCT01532635 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematologic Malignancy|Leukemia|Acute Lymphoblastic Leukemia|ALL|Acute Myelogenous Leukemia|AML|Chronic Lymphocytic Leukemia|CLL|Lymphoma|Hodgkin´s Lymphoma|Non-hodgkin´s Lymphoma|Myeloma | 2012-03 | PHASE2 |
| NCT06013423 | Fred Hutchinson Cancer Center|National Cord Blood Network | Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Blastic Plasmacytoid Dendritic Cell Neoplasm|Hematopoietic and Lymphatic System Neoplasm|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2024-07-23 | PHASE2 |
| NCT01509300 | Asan Medical Center | Acute Leukemia|Myelodysplastic Syndrome|Solid Tumors | 2012-01 | PHASE1|PHASE2 |
| NCT00522548 | University of Pennsylvania|Novartis Pharmaceuticals | Transplants and Implants | 2007-03 | PHASE4 |
| NCT00157014 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Heart Diseases|Heart Transplantation | 2004-05-10 | PHASE3 |
| NCT01707004 | University of Wisconsin, Madison|National Cancer Institute (NCI) | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia | 2013-05-16 | PHASE2 |
| NCT01005316 | National Institute of Allergy and Infectious Diseases (NIAID)|National Heart, Lung, and Blood Institute (NHLBI) | Pediatric Heart Transplantation|Pediatric Heart Transplant Recipients | 2010-01 | |
| NCT00555321 | Bristol-Myers Squibb | Immunosuppression in Solid Organ Transplant | 2008-01 | PHASE2 |
| NCT00118352 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Juvenile Myelomonocytic Leukemia|Mast Cell Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2005-03 | PHASE2 |
| NCT00910663 | Teva Pharmaceuticals USA | Healthy | 2006-10 | PHASE1 |
| NCT00556933 | University of Nebraska|Genzyme, a Sanofi Company | End-stage Renal Disease | 2004-04-01 | PHASE4 |
| NCT01652014 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2014-01 | PHASE2 |
| NCT04936971 | Edoardo Melilli | Kidney Transplantation|Cytomegalovirus Infections | 2021-09 | PHASE4 |
| NCT00054353 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Refractory Multiple Myeloma | 2002-10 | PHASE1|PHASE2 |
| NCT00281983 | German CLL Study Group | Chronic Lymphocytic Leukemia | 2000-06 | PHASE1|PHASE2 |
| NCT00003954 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma | 1999-03 | PHASE1|PHASE2 |
| NCT03249831 | City of Hope Medical Center|California Institute for Regenerative Medicine (CIRM) | Sickle Cell Disease|Sickle Cell Disorder|Hemoglobinopathies|Thalassemia|Anemia, Sickle Cell | 2019-01-04 | PHASE1 |
| NCT07214688 | Hackensack Meridian Health | Allogeneic Stem Cell Transplant Recipient | 2026-01-06 | PHASE2 |
| NCT06942156 | Chong Kun Dang Pharmaceutical | Heart Transplant | 2025-08-14 | PHASE4 |
| NCT00425802 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma | 2006-11-28 | PHASE2 |
| NCT02833805 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Severe Aplastic Anemia|Aplastic Anemia|Bone Marrow Failure|Immunosuppression | 2016-09 | PHASE2 |
| NCT04810156 | Inge Marie Svane | Hepatitis, Drug-Induced | 2021-04-07 | PHASE2 |
| NCT00119392 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | B-cell Chronic Lymphocytic Leukemia|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstr?m Macroglobulinemia | 2004-06 | PHASE2 |
| NCT00322101 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Acute Myeloid Leukemia+Transient Myeloproliferative Disorder|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes | 2006-01 | PHASE3 |
| NCT00203281 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Kidney Transplantation|Plasmapheresis | 2003-02 | |
| NCT03582878 | Institute for Clinical and Experimental Medicine | Diabetes Mellitus, Type 1 | 2004-01-01 | PHASE4 |
| NCT00036738 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Lymphoblastic Leukemia in Remission|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Blastic Phase|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase of Disease|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Disease | 2001-07-13 | PHASE2 |
| NCT04262843 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|High Risk Myelodysplastic Syndrome|Myelodysplastic Syndrome | 2020-02-07 | PHASE2 |
| NCT03388008 | Washington University School of Medicine|National Heart, Lung, and Blood Institute (NHLBI)|Bristol-Myers Squibb | Lung Transplant Rejection|Antibody-mediated Rejection | 2019-12-17 | PHASE2 |
| NCT03315052 | Montefiore Medical Center | Acute Cellular Graft Rejection|Liver Transplant Rejection | 2019-01 | PHASE4 |
| NCT01760655 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Acute Myeloid Leukemia With FLT3+ITD Mutation|Acute Myeloid Leukemia With Gene Mutations|Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM|Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214|Aplastic Anemia|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Follicular Lymphoma|Hodgkin Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Myeloid Leukemia|Non-Hodgkin Lymphoma|Plasma Cell Myeloma|Polycythemia Vera|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Therapy-Related Acute Myeloid Leukemia | 2012-12-24 | PHASE2 |
| NCT04009525 | First Affiliated Hospital of Guangxi Medical University|Peking University People´s Hospital|Ruijin Hospital|The 923rd Hospital of Joint Logistics Support Force of People´s Liberation Army|LiuZhou People´s Hospital|The First People´s Hospital of Yunnan|Liuzhou Workers´ Hospital|Xinqiao Hospital of Chongqing|Affiliated Hospital of Youjiang University of Ethnic Medicine|Hainan People´s Hospital|Maoming People´s Hospital|Red Cross Hospital of Yulin City|Guilin Medical College|Wuzhou People´s Hospital|Guangxi Autonomous Region People´s Hospital|The 920th Hospital of Joint Logistics Support Force of People´s Liberation Army | Thalassemia Major | 2019-07-05 | PHASE4 |
| NCT00717314 | Hoffmann-La Roche | Liver Transplantation | 2008-05 | PHASE4 |
| NCT02446964 | City of Hope Medical Center|National Cancer Institute (NCI) | Adult Acute Lymphoblastic Leukemia in Complete Remission|Acute Myeloid Leukemia in Remission|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Childhood Acute Lymphoblastic Leukemia in Complete Remission | 2015-06-25 | PHASE1 |
| NCT00943228 | Nova Scotia Health Authority | Acute Rejection of Renal Transplant | 2010-02 | PHASE4 |
| NCT00195273 | Wyeth is now a wholly owned subsidiary of Pfizer | Graft vs Host Disease|Kidney Transplantation | 2004-11 | PHASE3 |
| NCT00972101 | M.D. Anderson Cancer Center | Stem Cell Transplantation|Leukemia|Lymphoma|Pediatric Disorders | 2009-09 | PHASE1 |
| NCT02199041 | St. Jude Children´s Research Hospital | Hematological Malignancies | 2014-07-11 | PHASE2 |
| NCT01283867 | Dr. Reddy´s Laboratories Limited | FED | 2007-11 | PHASE1 |
| NCT00025519 | Fox Chase Cancer Center|National Cancer Institute (NCI) | Kidney Cancer | 2001-06 | PHASE2 |
| NCT02187900 | Second Xiangya Hospital of Central South University | IgA Nephropathy | 2014-06 | PHASE3 |
| NCT00010361 | Fred Hutchinson Cancer Center | Metabolism, Inborn Errors|Granulomatous Disease, Chronic | 2000-11 | NA |
| NCT00187941 | University of Florida|Hoffmann-La Roche | Transplantation, Renal|Immunosuppression | 2005-08 | EARLY_PHASE1 |
| NCT02077556 | National Taiwan University Hospital | Drug Interaction Potentiation | 2014-04 | PHASE4 |
| NCT00060424 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | B-Cell Prolymphocytic Leukemia|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|T-Cell Prolymphocytic Leukemia | 2003-03 | PHASE2 |
| NCT01399047 | University of Rochester|Batten Disease Support and Research Assocation (BDSRA) | Juvenile Neuronal Ceroid Lipofuscinosis | 2011-07 | PHASE2 |
| NCT00893958 | Roxane Laboratories | Prophylaxis of Organ Rejection | 2006-01 | NA |
| NCT00117689 | Genzyme, a Sanofi Company | Liver Dysfunction|Rejection, Transplant|Transplantation, Liver | 2005-04 | PHASE2 |
| NCT00275535 | Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer|Genzyme, a Sanofi Company|Roche Pharma AG | Kidney Diseases | 2001-04 | PHASE4 |
| NCT00031655 | Fred Hutchinson Cancer Research Center+University of Washington Cancer Consortium|National Cancer Institute (NCI) | Adult Acute Lymphoblastic Leukemia in Remission|Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia | 2001-09 | PHASE2 |
| NCT02652468 | University of Wisconsin, Madison | Lymphoma | 2016-03-10 | NA |
| NCT06044493 | Chong Kun Dang Pharmaceutical | Kidney Transplant | 2023-11-14 | PHASE4 |
| NCT00489281 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Sickle Cell Disease | 2008-06-23 | PHASE2 |
| NCT00907907 | Teva Pharmaceuticals USA | Healthy | 2006-07 | PHASE1 |
| NCT00008177 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Secondary Myelodysplastic Syndromes|Untreated Adult Acute Myeloid Leukemia | 1999-07-27 | PHASE1 |
| NCT01269021 | Zhi-Hong Liu, M.D. | IgA Nephropathy (IgAN) | 2010-11 | NA |
| NCT00110058 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 2005-02 | PHASE2 |
| NCT00894088 | Roxane Laboratories | Prophylaxis of Organ Rejection | 2006-01 | NA |
| NCT00843856 | Imperial College Healthcare NHS Trust | Glomerulonephritis, Membranous | 2009-03-03 | PHASE4 |
| NCT00883129 | Michael Roth|National Heart, Lung, and Blood Institute (NHLBI)|Hoffmann-La Roche | Scleroderma|Interstitial Lung Disease | 2009-09 | PHASE2 |
| NCT04477200 | University of Michigan Rogel Cancer Center|National Cancer Institute (NCI) | Recurrent Glioblastoma|Recurrent Gliosarcoma|Recurrent Astrocytoma, Grade IV|Newly Diagnosed Glioblastoma|Newly Diagnosed Gliosarcoma|Newly Diagnosed Astrocytoma, Grade IV | 2020-08-05 | PHASE1 |
| NCT00376519 | Masonic Cancer Center, University of Minnesota | Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Secondary Myelofibrosis | 2007-05 | PHASE1 |
| NCT01954784 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma | 2013-10-07 | PHASE1 |
| NCT05974683 | Peking Union Medical College Hospital|Beijing Friendship Hospital|Tongji Hospital | Autoimmune Diseases | 2023-08-01 | NA |
| NCT01017029 | Novartis Pharmaceuticals | Cardiac Transplantation | 2009-09 | PHASE4 |
| NCT01044745 | University of Nebraska|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Graft Versus Host Disease|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia+Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Mycosis Fungoides+Sezary Syndrome|Stage I Small Lymphocytic Lymphoma|Stage II Adult T-cell Leukemia+Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Mycosis Fungoides+Sezary Syndrome|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Mycosis Fungoides+Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides+Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Waldenstr?m Macroglobulinemia | 2009-12-10 | PHASE2 |
| NCT01266148 | Novartis Pharmaceuticals | Renal Function and Chronic Allograft Vasculopathy | 2009-11 | PHASE4 |
| NCT01080443 | Panacea Biotec Ltd | Healthy Volunteers | 2008-06 | NA |
| NCT01392989 | Everett Meyer | Neural Tube Defects|Anemia|Leukemia, Myeloid|Bone Marrow Transplant Failure|Myelodysplastic Syndromes (MDS)|Myeloproliferative Disorders | 2011-03 | PHASE2 |
| NCT06973668 | M.D. Anderson Cancer Center | AML | 2025-07-22 | PHASE2 |
| NCT00874315 | Nationwide Children´s Hospital | Neuroblastoma | 2008-09 | PHASE2 |
| NCT00594308 | Indiana University | Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Lymphoma, Non-Hodgkin´s|Mantle-Cell Lymphoma|Hodgkin´s Disease|Multiple Myeloma|Myelofibrosis | 2007-10 | NA |
| NCT00189150 | University of Michigan|Hoffmann-La Roche | Kidney Transplant Recipient|Heart Transplant Recipient | 2005-04 | PHASE4 |
| NCT00005803 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Prolymphocytic Leukemia|Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Hodgkin Lymphoma|Recurrent Childhood Non-Hodgkin Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|T-Cell Chronic Lymphocytic Leukemia|T-Cell Prolymphocytic Leukemia | 1999-09 | PHASE1|PHASE2 |
| NCT01930890 | Biogen | Lupus Nephritis | 2013-11 | PHASE2 |
| NCT02921789 | Astellas Pharma Global Development, Inc.|Kyowa Kirin Co., Ltd. | Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS) | 2017-05-22 | PHASE2 |
| NCT00295425 | University Hospital Muenster|Hoffmann-La Roche | Psoriasis | 2000-05 | PHASE2 |
| NCT00352976 | Masonic Cancer Center, University of Minnesota | Fanconi Anemia | 2006-05-18 | PHASE2|PHASE3 |
| NCT00446251 | University of Washington|Genentech, Inc. | Kidney Failure, Chronic|Diabetic Nephropathies|Glomerulonephritis, IGA|Hypertension, Renal | 2006-12 | PHASE2 |
| NCT00573157 | EMD Serono|ZymoGenetics | Lupus Nephritis | 2007-12 | PHASE2|PHASE3 |
| NCT01659606 | Boston Children´s Hospital|Dana-Farber Cancer Institute|Children´s Hospital Medical Center, Cincinnati|Fred Hutch+University of Washington+Seattle Children´s Cancer Consortium|Baylor College of Medicine|Children´s Hospital of Philadelphia|University of Wisconsin, Madison|Karolinska University Hospital|Hackensack Meridian Health|Oslo University Hospital|Children´s Mercy Hospital Kansas City|University of Chicago|Massachusetts General Hospital | Dyskeratosis Congenita|Hoyeraal Hreidarsson Syndrome|Revesz Syndrome|Aplastic Anemia | 2012-07 | PHASE2 |
| NCT00204022 | Frédéric A. Houssiau, MD, PhD | Lupus Nephritis | 2001-02 | PHASE3 |
| NCT01203722 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Hematologic Malignancies | 2010-09 | PHASE1|PHASE2 |
| NCT02080195 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Maryland Stem Cell Research Fund | Lupus Erythematosus|Graft-versus-host Disease | 2016-09-13 | PHASE1|PHASE2 |
| NCT05027945 | National Cancer Institute (NCI) | Immunodeficiency|Hematopoietic Stem Cell Transplantation | 2023-02-23 | PHASE2 |
| NCT00023231 | National Institute of Allergy and Infectious Diseases (NIAID) | End-Stage Renal Disease | 2001-02 | NA |
| NCT00374231 | University of Cincinnati|Astellas Pharma Inc | Liver Transplantation | 2002-10 | PHASE4 |
| NCT02723786 | GlaxoSmithKline | Kidney Transplantation (Status Post) | 2016-08-27 | PHASE2 |
| NCT00469131 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan|Kyoto University | Hepatitis C|Liver Cirrhosis | 2003-09 | PHASE3 |
| NCT04083183 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI) | Non-Malignant Neoplasm | 2020-06-16 | PHASE1|PHASE2 |
| NCT07412470 | Sanofi | Kidney Transplant Rejection | 2026-03-13 | PHASE2|PHASE3 |
| NCT00290641 | Masonic Cancer Center, University of Minnesota|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes | 2001-04 | NA |
| NCT04904588 | Center for International Blood and Marrow Transplant Research|National Marrow Donor Program | Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Mixed Phenotype Acute Leukemia|Acute Leukemia|Myelodysplastic Syndromes|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Lymphoma | 2021-09-30 | PHASE2 |
| NCT00812786 | University Hospital, Limoges | Heart Transplant | 2007-07 | PHASE4 |
| NCT01428973 | University of Liege|AZ Sint-Jan AV|Ziekenhuis Netwerk Antwerpen (ZNA)|Jules Bordet Institute|University Hospital, Gasthuisberg|Universitair Ziekenhuis Brussel|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|University Hospital, Antwerp|Cliniques Universitaires de Mont-Godinne|Hospital de Jolimont|University Hospital, Ghent|AZ Delta | Graft-Versus-Host Disease|Hematological Malignancies | 2011-09 | PHASE2 |
| NCT00789308 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Clinical Islet Transplantation Consortium | Diabetes Mellitus, Type I | 2008-07-11 | PHASE2 |
| NCT07359859 | Memorial Sloan Kettering Cancer Center|Incyte Corporation | Hematologic Malignancies | 2026-01-20 | PHASE2 |
| NCT00849238 | University of Wisconsin, Madison | Primary Liver Transplant | | NA |
| NCT00568633 | Stanford University|Genzyme, a Sanofi Company | Leukemia, Myeloid|Leukemia|Acute Myeloid Leukemia (AML) | 2007-08 | PHASE3 |
| NCT00574496 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Lymphoma | 2007-11-13 | PHASE2 |
| NCT00185614 | Wen-Kai Weng | Blood Cancer|Multiple Myeloma | 2000-08 | PHASE2 |
| NCT06258915 | Assistance Publique - H?pitaux de Paris | Non Infectious Uveitis | 2024-03-01 | PHASE3 |
| NCT02424968 | Robert Lowsky|National Cancer Institute (NCI) | Acute Myeloid Leukemia|B-Cell Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Hodgkin Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|T-Cell Non-Hodgkin Lymphoma | 2015-06 | PHASE2 |
| NCT00005935 | National Heart, Lung, and Blood Institute (NHLBI) | Aplastic Anemia | 2000-06 | PHASE2 |
| NCT01446484 | Pirogov Russian National Research Medical University|Russian Academy of Medical Sciences | End-Stage Renal Disease|Kidney Failure | 2011-10 | PHASE1|PHASE2 |
| NCT05293509 | M.D. Anderson Cancer Center | Stem Cell Transplantation | 2022-03-02 | PHASE2 |
| NCT04220008 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Recurrent Aggressive Non-Hodgkin Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Burkitt Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent High Grade B-Cell Lymphoma|Recurrent T-Cell Non-Hodgkin Lymphoma|Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | 2021-10-29 | PHASE2 |
| NCT02990286 | University Hospital, Tours | Lung Disease, Interstitial | 2017-01-20 | PHASE3 |
| NCT06859424 | Center for International Blood and Marrow Transplant Research|National Marrow Donor Program|Incyte Corporation | AML (Acute Myelogenous Leukemia)|Acute Lymphoid Leukemia (ALL)|Acute Leukemia (Category)|MDS (Myelodysplastic Syndrome)|CML (Chronic Myelogenous Leukemia)|CLL (Chronic Lymphocytic Leukemia)|Prolymphocyctic Leukemia|Chronic Myelomonocytic Leukemia (CMML)|Myeloproliferative Neoplasm (MPN)|Lymphoma|Myelofibrosis | 2025-07-25 | PHASE2 |
| NCT06789315 | Institute of Liver and Biliary Sciences, India | Alcoholic Hepatitis | 2025-01-20 | NA |
| NCT02909335 | Rennes University Hospital | Liver Transplantation | 2016-11 | PHASE3 |
| NCT00318474 | St. Joseph´s Hospital and Medical Center, Phoenix | IgA Nephropathy | 2002-01 | PHASE3 |
| NCT00420537 | University of Bologna | Kidney Dysfunction|Heart Transplantation | 2006-09 | PHASE4 |
| NCT00223301 | University of Texas Southwestern Medical Center|Roche Pharma AG|Biogen | Multiple Sclerosis | 2004-07 | PHASE2|PHASE3 |
| NCT03504241 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN)|PPD Development, LP|Rho Federal Systems Division, Inc. | Kidney Transplantation|Renal Transplantation|Renal Transplant Recipient | 2018-07-30 | PHASE1 |
| NCT00619645 | University of California, Davis | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2007-06 | PHASE2 |
| NCT00087581 | Hoffmann-La Roche | Kidney Transplantation | 2004-06 | PHASE4 |
| NCT01288131 | Chulalongkorn University | Anti-r-HuEpo Associated PRCA Subjects | 2009-01 | PHASE3 |
| NCT02904772 | UniQure Biopharma B.V.|Chiesi Farmaceutici S.p.A. | LPL Deficiency | 2016-10 | PHASE2 |
| NCT00377637 | Hoffmann-La Roche|Aspreva Pharmaceuticals | Lupus Nephritis | 2005-07 | PHASE3 |
| NCT00790439 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type I | 2008-07 | PHASE2 |
| NCT04473911 | Zachariah Michael DeFilipp|Regimmune Corporation | GVHD|AML|ALL|MDS|MPN|CMML|Hodgkin Lymphoma|Non Hodgkin Lymphoma|Blood Stem Cell Transplant Failure|Graft Vs Host Disease|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Myeloproliferative Disorder|Chronic Myelomonocytic Leukemia|Chemosensitive Hodgkin Lymphoma | 2020-08-14 | PHASE1 |
| NCT01711489 | Astellas Pharma Global Development, Inc.|Basilea Pharmaceutica International Ltd | Healthy Subjects|Pharmacokinetics of Isavuconazole|Pharmacokinetics of Plasma Mycophenolic Acid (MPA)|Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG) | 2012-03 | PHASE1 |
| NCT06752694 | Fred Hutchinson Cancer Center|Incyte Corporation | Aplastic Anemia | 2025-09-25 | PHASE2 |
| NCT00430677 | Bristol-Myers Squibb | Systemic Lupus Erythematosus | 2007-06 | PHASE2|PHASE3 |
| NCT05256537 | Ronald Paquette | Hematologic Neoplasms | 2022-04-26 | PHASE2 |
| NCT00343798 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Damon Runyon Cancer Research Foundation | Accelerated Phase Chronic Myelogenous Leukemia|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Prolymphocytic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma | 2006-04 | PHASE1 |
| NCT01856257 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation | Primary Renal Allograft Candidate|Kidney Transplantation | 2013-07 | PHASE2 |
| NCT00275509 | Johns Hopkins University | Kidney Failure, Chronic | 2007-01 | PHASE3 |
| NCT00793572 | Fred Hutchinson Cancer Center|Millennium Pharmaceuticals, Inc.|National Cancer Institute (NCI) | Refractory Plasma Cell Myeloma | 2008-10 | PHASE2 |
| NCT00290628 | Masonic Cancer Center, University of Minnesota|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Diamond-blackfan Anemia|Fanconi Anemia|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1999-10 | NA |
| NCT01871441 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Malignant Neoplasm | 2013-05-17 | PHASE2 |
| NCT00494741 | Mario Negri Institute for Pharmacological Research|Agenzia Italiana del Farmaco | Kidney Transplant | 2007-05 | PHASE4 |
| NCT04530487 | M.D. Anderson Cancer Center | Desmoplastic Small Round Cell Tumor|Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Recurrent Desmoplastic Small Round Cell Tumor|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Neuroblastoma|Recurrent Rhabdomyosarcoma|Refractory Desmoplastic Small Round Cell Tumor|Refractory Malignant Peripheral Nerve Sheath Tumor|Refractory Malignant Solid Neoplasm|Refractory Neuroblastoma|Refractory Rhabdomyosarcoma | 2020-08-19 | PHASE2 |
| NCT00729768 | Genentech, Inc. | Kidney Transplantation | | PHASE2|PHASE3 |
| NCT00285350 | FDA Office of Orphan Products Development|Duke University | Myasthenia Gravis | 2002-09 | PHASE3 |
| NCT01982682 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematopoietic+Lymphoid Cancer | 2013-11-04 | PHASE2 |
| NCT00307645 | Assistance Publique - H?pitaux de Paris | ANCA Associated Systemic Vasculitis Including Wegener´s|Granulomatosis and Microscopic Polyangiitis and|Renal Limited Vasculitis | 2003-05 | PHASE3 |
| NCT00003572 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1998-08 | PHASE2 |
| NCT04849533 | University of Cincinnati | Kidney Transplant Rejection | 2021-04-09 | PHASE4 |
| NCT02294552 | Ivan S Moiseev | Acute Myeloid Leukemia|Acute Lymphoid Leukemia|Lymphoma|Myelodysplastic Syndromes|Chronic Lymphocytic Leukemia|Immune System Diseases | 2014-10 | PHASE2 |
| NCT05207358 | Institutul Clinic Fundeni | Lupus Nephritis | 2022-03-02 | PHASE4 |
| NCT00824135 | St. Jude Children´s Research Hospital|Genzyme, a Sanofi Company | Hematologic Malignancies | 2009-01 | PHASE1 |
| NCT02217410 | Novartis Pharmaceuticals | Kidney Transplantation | 2015-02-05 | PHASE1|PHASE2 |
| NCT00669890 | New York Medical College | Acute Myeloid Leukemia|Juvenile Myelomonocytic Leukemia|Myelodysplastic Syndrome | 2004-05 | PHASE1 |
| NCT00423826 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous Condition|Secondary Myelofibrosis | 2007-01 | |
| NCT00658320 | Novartis | Kidney Transplantation | 2008-02 | PHASE3 |
| NCT00199667 | University Hospital, Limoges|Hoffmann-La Roche | Kidney Transplant Recipients | 2002-10 | PHASE4 |
| NCT01154387 | Tolera Therapeutics, Inc | End Stage Renal Disease|Renal Transplant | 2010-07 | PHASE1|PHASE2 |
| NCT01363752 | Astellas Pharma Inc | Kidney Transplantation | 2011-03-08 | PHASE4 |
| NCT00719849 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2005-11 | PHASE2 |
| NCT06055608 | National Institute of Allergy and Infectious Diseases (NIAID) | Kidney Transplant | 2024-05-22 | PHASE2 |
| NCT00425438 | Hoffmann-La Roche | Lupus Nephritis | 2007-03 | PHASE3 |
| NCT02711826 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation | Kidney Transplant|Adult Living Donor Kidney Transplant Recipients|Renal Transplant|Living Kidney Donor | 2016-09-20 | PHASE1|PHASE2 |
| NCT01014442 | Hoffmann-La Roche | Lung Transplantation | 2010-01 | PHASE3 |
| NCT00946023 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Lymphoma|B-cell Lymphoma|Non Hodgkin Lymphoma|Chronic Lymphocytic Leukemia | 2009-07 | PHASE2 |
| NCT00005851 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Recurrent Renal Cell Cancer|Stage IV Renal Cell Cancer | 2000-02 | PHASE1|PHASE2 |
| NCT00004567 | National Institute of Allergy and Infectious Diseases (NIAID) | Vasculitis|Wegener´s Granulomatosis | 2000-02 | PHASE2 |
| NCT00166153 | Emory University | Cardiac Transplantation | 2003-01 | NA |
| NCT01231412 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Diffuse Large B-Cell Lymphoma|Hematopoietic and Lymphoid Cell Neoplasm|Indolent Non-Hodgkin Lymphoma|Mantle Cell Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Plasma Cell Myeloma|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Hodgkin Lymphoma|Small Lymphocytic Lymphoma|T-Cell Chronic Lymphocytic Leukemia|Waldenstrom Macroglobulinemia | 2010-11 | PHASE3 |
| NCT01434472 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Post-Transplant Lymphoproliferative Disorder|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Burkitt Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Burkitt Lymphoma|Refractory Diffuse Large B-Cell Lymphoma | 2011-11-16 | PHASE2 |
| NCT04444843 | First Affiliated Hospital Xi´an Jiaotong University | Kidney Transplant Recipients | 2021-01-22 | PHASE4 |
| NCT01384513 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Aplastic Anemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Essential Thrombocythemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Juvenile Myelomonocytic Leukemia|Mastocytosis|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Polycythemia Vera|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Waldenstr?m Macroglobulinemia | 2011-08-04 | PHASE2 |
| NCT00021489 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | | PHASE2 |
| NCT00498316 | M.D. Anderson Cancer Center|ViaCell|National Institutes of Health (NIH)|National Cancer Institute (NCI) | Myelodysplastic Syndrome|Leukemia | 2007-07-03 | PHASE1 |
| NCT01884571 | Emory University|ALS Association | Amyotrophic Lateral Sclerosis (ALS) | 2013-10 | PHASE2 |
| NCT00166712 | Northwestern University|Roche Pharma AG | Kidney Transplant Failure and Rejection | 2005-04 | PHASE4 |
| NCT00534430 | City of Hope Medical Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 2000-02-29 | PHASE2 |
| NCT06676384 | Christian Medical College, Vellore, India|Medical Research Council|India Alliance | IgA Nephropathy|Renal Insufficiency, Chronic|IgA Vasculitis|IGA Glomerulonephritis | 2025-02-15 | PHASE4 |
| NCT00027547 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia | 2001-07 | PHASE1|PHASE2 |
| NCT05115630 | M.D. Anderson Cancer Center | Myeloid Malignancies|Acute Myeloid Leukemia|Myelodysplastic Syndrome|Chronic Myeloid Leukemia | 2022-04-08 | PHASE2 |
| NCT02342145 | Zhongming Zhang|Liuzhou Workers´ Hospital|Hainan General Hospital|McMaster University|Guangxi Key Laboratory of Thalassemia Research|NHC Key Laboratory of Thalassemia Medicine | Beta-Thalassemia Major|Graft-versus-host Disease (GVHD) | 2015-04 | PHASE4 |
| NCT05916781 | Chinese SLE Treatment And Research Group|Peking Union Medical College Hospital | Systemic Lupus Erythematosus|Lupus Nephritis | 2023-07-01 | PHASE4 |
| NCT02091414 | Hoffmann-La Roche | Heart Transplantation | 2006-08 | PHASE3 |
| NCT04370301 | Fred Hutchinson Cancer Center | Primary Myelofibrosis|Secondary Myelofibrosis | 2021-02-09 | PHASE2 |
| NCT02208037 | National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI) | Acute Leukemia|Chronic Myelogenous Leukemia|Myelodysplasia|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse|Hodgkin´s Lymphoma | 2014-08 | PHASE2 |
| NCT00301951 | University of California, San Francisco|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2004-09 | PHASE1 |
| NCT05039619 | Hoffmann-La Roche|Genentech, Inc. | Lupus Nephritis | 2022-05-12 | PHASE2 |
| NCT02981212 | Yonsei University|Chong Kun Dang Pharmaceutical Corp.|Kyung Hee University Hospital at Gangdong|Kyungpook National University Hospital|Pusan National University Yangsan Hospital|Inje University|Seoul St. Mary´s Hospital|Chonbuk National University Hospital | IgA Nephropathy | 2016-06 | PHASE4 |
| NCT02677181 | Chinese PLA General Hospital|309th Hospital of Chinese People´s Liberation Army|Beijing Naval General Hospital|Space Center Hospital, Peking University | aGVHD | 2016-01 | PHASE4 |
| NCT00626197 | Genentech, Inc.|Roche Pharma AG | Lupus Nephritis|Systemic Lupus Erythematosus | 2008-02-15 | PHASE3 |
| NCT00630253 | Masonic Cancer Center, University of Minnesota | Fanconi Anemia | 2000-02-17 | PHASE1|PHASE2 |
| NCT00404794 | Hospital Authority, Hong Kong|The University of Hong Kong | Lupus Nephritis|Glomerulonephritis, Membranous | 2005-11 | PHASE3 |
| NCT03426969 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Primary Myelofibrosis|Secondary Myelofibrosis | 2018-01-31 | EARLY_PHASE1 |
| NCT00782379 | Northside Hospital, Inc. | Leukemia|Lymphoma|Myelodysplastic Syndromes | 2008-10 | PHASE2 |
| NCT01903798 | Southern California Institute for Research and Education|University of Southern California|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|VA Long Beach Healthcare System|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcoholic Hepatitis | 2014-12 | PHASE2 |
| NCT03192397 | Roswell Park Cancer Institute | Acute Myeloid Leukemia in Remission|Adult Acute Lymphoblastic Leukemia in Complete Remission|Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission|Chronic Myelomonocytic Leukemia in Remission|Graft Versus Host Disease|Hodgkin Lymphoma|Minimal Residual Disease|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Plasma Cell Myeloma|Severe Aplastic Anemia|Waldenstrom Macroglobulinemia | 2017-08-09 | PHASE1|PHASE2 |
| NCT00300274 | Novartis Pharmaceuticals | Graft Rejection | 2006-01 | PHASE3 |
| NCT00919503 | Fred Hutchinson Cancer Center|medac GmbH|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Non-Neoplastic Hematologic and Lymphocytic Disorder | 2009-07-31 | PHASE2 |
| NCT00005941 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Cervical Cancer|Vaginal Cancer | 1999-11 | PHASE2 |
| NCT03247088 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia | 2017-07-30 | PHASE1|PHASE2 |
| NCT03156452 | University Hospitals Bristol and Weston NHS Foundation Trust|Cardiff University | Immune Thrombocytopenia | 2017-10-25 | PHASE3 |
| NCT00740467 | Institut Paoli-Calmettes | Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Precancerous Condition | 2008-01 | PHASE2 |
| NCT00908128 | Teva Pharmaceuticals USA | Healthy | 2006-08 | PHASE1 |
| NCT01252667 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia | 2011-01-25 | PHASE2 |
| NCT06114953 | Lee´s Pharmaceutical Limited | Kidney Transplant Immunosuppression | 2023-01-01 | PHASE4 |
| NCT00103792 | University Medical Center Groningen | Wegener´s Granulomatosis|Vasculitis | 2004-12 | PHASE3 |
| NCT00334672 | Children´s Cancer and Leukaemia Group | Nonneoplastic Condition | 2006-03 | PHASE3 |
| NCT01085097 | Teva Branded Pharmaceutical Products R&D, Inc. | Lupus Nephritis | 2010-09-01 | PHASE2 |
| NCT00753103 | University Hospital Birmingham NHS Foundation Trust | Wegener´s Granulomatosis|Renal Limited Vasculitis|Microscopic Polyangiitis | 2003-01 | PHASE2 |
| NCT00543569 | Astellas Pharma Inc | Kidney Transplantation | 2008-02 | PHASE2 |
| NCT02081183 | Hoffmann-La Roche | Lupus Nephritis | 2006-03 | PHASE3 |
| NCT01002742 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Graft-versus-Host Disease|Immune System Disorders | 2010-01 | PHASE3 |
| NCT00531635 | King Faisal Specialist Hospital & Research Center | Post Transplant in Immunosuppression w+CSA & Mycophenolate Mofetil | 2002-07 | PHASE1 |
| NCT03899103 | Nilratan Sircar Medical College|Heidelberg University | Steroid-Dependent Nephrotic Syndrome | 2019-05-15 | PHASE3 |
| NCT00796068 | Fred Hutchinson Cancer Center | Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Blasts Under 5 Percent of Bone Marrow Nucleated Cells|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Myelodysplastic Syndrome (MDS) | 2009-02-24 | PHASE2 |
| NCT00228020 | Novartis | Pediatric Kidney Transplantation | 2001-05 | PHASE3 |
| NCT01220297 | Stanford University | Hematologic Diseases|Acute-graft-versus-host Disease|Leukemia|Non-Hodgkin Lymphoma (NHL)|Hodgkin Lymphoma | 2006-08 | PHASE2 |
| NCT04877288 | Bristol-Myers Squibb | Renal Allograft Recipients | 2021-07-21 | PHASE3 |
| NCT01342289 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Hodgkin´s Lymphoma|Leukemia|Myelodysplastic Syndrome(MDS)|Multiple Myeloma|Non Hodgkin´s Lymphoma | 2011-08 | PHASE1 |
| NCT03170323 | Guangdong Provincial People´s Hospital | Idiopathic Membranous Nephropathy | 2018-07-01 | PHASE4 |
| NCT00093743 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|Fanconi Anemia|Previously Treated Myelodysplastic Syndromes | 2000-01 | PHASE1 |
| NCT02075242 | Asan Medical Center | HEPATITIS | 2014-01 | PHASE4 |
| NCT00707759 | Fondo Nacional de Desarrollo Científico y Tecnológico, Chile | Kidney Diseases | 2008-06 | PHASE3 |
| NCT00400400 | Novartis Pharmaceuticals | Renal Transplantation | 2006-10 | PHASE4 |
| NCT00151632 | Rennes University Hospital|Ministry of Health, France | Evidence of Liver Transplantation | 2003-05 | PHASE3 |
| NCT00709592 | Virginia Commonwealth University|Genzyme, a Sanofi Company | Non-Hodgkin´s Lymphoma|Leukemia|Multiple Myeloma|Acute Myeloid Leukemia|Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome | 2008-07-21 | PHASE2 |
| NCT03018223 | H. Lee Moffitt Cancer Center and Research Institute | Non-Hodgkin´s Lymphoma|Acute Leukemia in Remission|Chronic Myeloid Leukemia|Primary Myelofibrosis|Chronic Myelomonocytic Leukemia|Myelodysplastic Syndromes|Hodgkin Lymphoma|Multiple Myeloma | 2017-01-31 | PHASE1 |
| NCT00414128 | Cambridge University Hospitals NHS Foundation Trust|Aspreva Pharmaceuticals|Vifor Pharma | Vasculitis | 2007-03 | PHASE2|PHASE3 |
| NCT00788567 | Hoffmann-La Roche | Kidney Transplantation | 2005-06 | PHASE3 |
| NCT02880293 | Memorial Sloan Kettering Cancer Center | Hematologic Malignancy | 2016-08-23 | NA |
| NCT02095418 | Samsung Medical Center | Diabetes | 2014-02 | NA |
| NCT05129410 | First Affiliated Hospital Xi´an Jiaotong University | Idiopathic Inflammatory Myopathy|Interstitial Lung Disease | 2020-12-01 | PHASE4 |
| NCT00006350 | University of Maryland, Baltimore | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2000-01 | PHASE2 |
| NCT01595984 | Centre Hospitalier Universitaire, Amiens|Novartis | Kidney Failure | 2012-05-03 | PHASE3 |
| NCT06412497 | Masonic Cancer Center, University of Minnesota | Severe Aplastic Anemia|Acquired Amegakaryocytic Thrombocytopenia|Acquired Pure Red Cell Aplasia|Paroxysmal Nocturnal Hemoglobinuria | 2024-06-05 | PHASE2 |
| NCT06288932 | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Immune Thrombocytopenia Purpura | 2023-08-18 | PHASE3 |
| NCT06375005 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Diffuse Cutaneous Systemic Sclerosis | 2025-01-06 | PHASE2 |
| NCT05088356 | Stanford University|Orca Biosystems, Inc. | Allogeneic Hematopoietic Cell Transplantation (HCT)|Advanced Hematologic Malignancies|Acute Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndromes|Myeloproliferative Disorders | 2021-09-07 | PHASE1 |
| NCT04424862 | Beijing Friendship Hospital | Efficacy | 2020-06-09 | PHASE4 |
| NCT03200002 | Chitwan Medical College | To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients | 2014-01-01 | PHASE2 |
| NCT00006251 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Undifferentiated Leukemia|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Juvenile Myelomonocytic Leukemia|Mast Cell Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Myeloid+NK-cell Acute Leukemia|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Systemic Amyloidosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Renal Cell Cancer|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage II Multiple Myeloma|Stage III Multiple Myeloma|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2000-05 | PHASE1|PHASE2 |
| NCT00119366 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes | 2003-05 | PHASE2 |
| NCT00683969 | Hoffmann-La Roche|Aspreva Pharmaceuticals | Myasthenia Gravis, Generalized | 2004-08 | PHASE3 |
| NCT03791827 | Xiqiang Dang|The Children´s Hospital Affiliated to Suzhou University|Shandong Provincial Hospital|Guizhou Provincial People´s Hospital|LanZhou University|The First Affiliated Hospital of Inner Mongolia Medical College|People´s Hospital of Zhangjiajie|Puyang Oilfield General Hospital|The First Affiliated Hospital of Anhui Medical University|Guizhou Maternal and Child Health Care Hospital|Second Affiliated Hospital of Wenzhou Medical University|Shenzhen Children´s Hospital|The Second Affiliated Hospital of Harbin Medical University|Yichang Central People´s Hospital|Xian Children´s Hospital|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology|The First People´s Hospital of Yunnan|The First Affiliated Hospital of Xiamen University|The First Affiliated Hospital of Xinxiang Medical College|Shanxi Provincial Maternity and Children´s Hospital|Liaocheng People´s Hospital|Fujian Provincial Hospital|First Affiliated Hospital of Guangxi Medical University|Lanzhou University Second Hospital|Guangzhou First People´s Hospital|The Second Hospital of Shandong University|Children´s Hospital of Hebei Province|Beijing Children´s Hospital|Zhengzhou Children´s Hospital|Children´s Hospital of Chongqing Medical University|Wuxi Women´s & Children´s Hospital|The Children´s Hospital of Fudan University|Shanghai Children´s Medical Center|Qilu Children´s Hospital of Shandong University | Lupus Nephritis|Children|Steroid|Immunosuppressive Treatment | 2018-12-01 | |
| NCT00006042 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1999-12 | PHASE1 |
| NCT00563589 | Hospital Authority, Hong Kong|Hoffmann-La Roche | Graft vs Host Disease|Hematopoietic Stem Cell Transplantation | 2003-08 | NA |
| NCT00053989 | Roswell Park Cancer Institute | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Fanconi Anemia|Aplastic Anemia | 2002-01-29 | PHASE2 |
| NCT00997958 | Columbia University | Pancreatic Cancer | 2004-06 | PHASE1 |
| NCT00594932 | Oklahoma Medical Research Foundation|NYU Langone Health | Systemic Lupus Erythematosus|Arthritis | 2006-11 | PHASE1|PHASE2 |
| NCT01904136 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Acute Myeloid Leukemia With Gene Mutations|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Therapy-Related Acute Myeloid Leukemia | 2014-04-22 | PHASE1|PHASE2 |
| NCT02435901 | Northwell Health | Sickle Cell Disease|Beta Thalassemia-Major | 2008-12 | PHASE1|PHASE2 |
| NCT02954198 | Medical University of South Carolina | Immunosuppression | 2016-12-01 | NA |
| NCT05303272 | Tongji Hospital|Wuhan Central Hospital|Wuhan Hospital of Traditional Chinese Medicine | Pemphigus Vulgaris | 2021-02-01 | PHASE4 |
| NCT00281619 | Children´s Hospital Medical Center, Cincinnati|Hoffmann-La Roche | Kidney Transplant | 2006-01 | |
| NCT00719888 | Fred Hutchinson Cancer Center | Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Burkitt Lymphoma|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Follicular Lymphoma|Lymphoblastic Lymphoma|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Non-Hodgkin Lymphoma|Plasma Cell Myeloma|Prolymphocytic Leukemia|Refractory Anemia|Small Lymphocytic Lymphoma | 2005-11-18 | PHASE2 |
| NCT00758602 | Hoffmann-La Roche | Kidney Transplantation | 2008-09 | PHASE4 |
| NCT04376528 | West China Hospital | Hepatitis, Autoimmune|Primary Biliary Cholangitis|Immunosuppression | 2021-06-16 | PHASE4 |
| NCT06650124 | Institute of Liver and Biliary Sciences, India | Autoimmune Hepatitis | 2024-11-01 | PHASE2|PHASE3 |
| NCT04776850 | M.D. Anderson Cancer Center | Beta Thalassemia Major|Sickle Beta 0 Thalassemia|Sickle Beta Plus Thalassemia|Sickle Beta Thalassemia|Sickle Cell Disease|Sickle Cell-SS Disease | 2020-12-29 | EARLY_PHASE1 |
| NCT02743247 | Seoul National University Hospital|Ministry of Food and Drug Safety, Korea | Healthy Volunteers | 2015-10 | PHASE1 |
| NCT00183248 | University of Miami|Immune Tolerance Network (ITN) | Kidney Transplantation|Kidney Disease|Kidney Failure | 2004-09 | PHASE1|PHASE2 |
| NCT00004485 | Fred Hutchinson Cancer Center | Sickle Cell Anemia | 1999-12 | PHASE1|PHASE2 |
| NCT00991510 | Teva Branded Pharmaceutical Products R&D, Inc.|Parexel | Stable Renal Transplant Recipients | 2009-08 | PHASE4 |
| NCT00003196 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage II Multiple Myeloma|Stage III Multiple Myeloma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 1997-09 | NA |
| NCT00862979 | Novartis Pharmaceuticals | Heart Transplantation | 2009-02-24 | PHASE4 |
| NCT02653196 | Montefiore Medical Center|Children´s Hospital Los Angeles|Nationwide Children´s Hospital | Neuroepithelial Tumor|Solid Tumor|Allogeneic Hematopoietic Stem Cell Transplantation | 2015-09 | EARLY_PHASE1 |
| NCT03943147 | Bristol-Myers Squibb | Lupus Nephritis | 2019-07-15 | PHASE2 |
| NCT01529827 | Roswell Park Cancer Institute | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Aplastic Anemia|Burkitt Lymphoma|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Congenital Amegakaryocytic Thrombocytopenia|Diamond-Blackfan Anemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Juvenile Myelomonocytic Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Paroxysmal Nocturnal Hemoglobinuria|Peripheral T-cell Lymphoma|Polycythemia Vera|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Secondary Myelofibrosis|Severe Combined Immunodeficiency|Severe Congenital Neutropenia|Shwachman-Diamond Syndrome|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Waldenstrom Macroglobulinemia|Wiskott-Aldrich Syndrome | 2012-02-28 | PHASE2 |
| NCT04195633 | Fred Hutchinson Cancer Center|medac GmbH | Acute Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Adult Diffuse Large Cell Lymphoma|Anaplastic Large Cell Lymphoma|Burkitt Lymphoma|Chronic Myeloid Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Hodgkin Lymphoma|Lymphoblastic Lymphoma|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Prolymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Follicular Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Small Lymphocytic Lymphoma | 2021-01-25 | PHASE2 |
| NCT04688021 | Yi Luo | Leukemia|Graft-versus-host-disease | 2020-12-03 | PHASE2 |
| NCT00230035 | National Institute of Allergy and Infectious Diseases (NIAID) | Systemic Lupus Erythematosus | 2005-09 | PHASE2 |
| NCT02861417 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Hematopoietic and Lymphoid Cell Neoplasm|High Risk Acute Myeloid Leukemia|High Risk Myelodysplastic Syndrome|Lymphoproliferative Disorder|Myelodysplastic Syndrome|Myelodysplastic+Myeloproliferative Neoplasm|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent High Risk Myelodysplastic Syndrome|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma | 2016-08-05 | PHASE2 |
| NCT05236036 | Northwestern University|National Cancer Institute (NCI) | Astrocytoma|Glioblastoma|Glioblastoma, IDH-Wildtype|MGMT-Unmethylated Glioblastoma|Recurrent Glioblastoma | 2022-08-08 | PHASE1 |
| NCT04700709 | Chong Kun Dang Pharmaceutical | Kidney Transplantation | 2021-01 | PHASE4 |
| NCT00255684 | University of Rochester | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2003-12 | NA |
| NCT02251821 | Fred Hutchinson Cancer Center|Incyte Corporation|National Cancer Institute (NCI) | Primary Myelofibrosis|Secondary Myelofibrosis | 2014-10-20 | PHASE2 |
| NCT00049504 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hematopoietic+Lymphoid Cancer|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage II Multiple Myeloma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Mycosis Fungoides+Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Childhood Hodgkin Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides+Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2002-01 | PHASE2 |
| NCT01471067 | M.D. Anderson Cancer Center|American Stem Cell, Inc.|National Cancer Institute (NCI) | Blood And Marrow Transplantation|Leukemia|Lymphoma|Transplantation Infection|Transplantation, Bone Marrow | 2012-07-13 | PHASE1 |
| NCT00352092 | University of Cincinnati|Roche Pharma AG | Renal Transplant | 2002-06 | PHASE4 |
| NCT00795132 | University of Utah | Acute Leukaemia|Chronic Disease|Leukemia|Myelodysplasia|Lymphoma | 2004-04 | PHASE2 |
| NCT00423514 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes | 2006-11-20 | PHASE1|PHASE2 |
| NCT00204230 | University Hospital Muenster|Hoffmann-La Roche | Immunosuppressive Agents|Kidney Failure, Chronic|Kidney Transplantation | 1999-10 | NA |
| NCT00354172 | Masonic Cancer Center, University of Minnesota | Leukemia|Myelodysplastic Syndromes | 2006-02 | PHASE2 |
| NCT01513044 | Dr. Reddy´s Laboratories Limited | Healthy | 2009-01 | PHASE1 |
| NCT02630628 | The University of Hong Kong | Lupus Nephritis | 2015-12-05 | PHASE3 |
| NCT03490539 | Duke University|Beth Israel Deaconess Medical Center|Patient-Centered Outcomes Research Institute | Neurological Disorder|Autoimmune Diseases | 2018-05-07 | |
| NCT02498977 | King´s College London|King´s College Hospital NHS Trust|National Institute for Health Research, United Kingdom | Transplantation, Liver | 2015-10 | PHASE4 |
| NCT00281879 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms|Unusual Cancers of Childhood | 2006-02 | PHASE2 |
| NCT00295997 | University of California, San Francisco|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Kidney Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2005-05 | NA |
| NCT00296348 | Astellas Pharma Inc | Kidney Transplantation | 2005-11 | PHASE3 |
| NCT03108274 | Alexion Pharmaceuticals, Inc.|Achillion, a wholly owned subsidiary of Alexion | Healthy | 2017-04-18 | PHASE1 |
| NCT00121810 | Hoffmann-La Roche | Kidney Transplantation | 2003-08 | PHASE4 |
| NCT00506948 | M.D. Anderson Cancer Center|Genzyme, a Sanofi Company | Hematological Malignancies|Myelodysplastic Syndrome|Leukemia|Lymphoma | 2006-09 | PHASE2 |
| NCT02548468 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides and Sezary Syndrome|Stage IIB Mycosis Fungoides and Sezary Syndrome|Stage IIIA Mycosis Fungoides and Sezary Syndrome|Stage IIIB Mycosis Fungoides and Sezary Syndrome|Stage IVA Mycosis Fungoides and Sezary Syndrome|Stage IVB Mycosis Fungoides and Sezary Syndrome | 2015-11-20 | PHASE1 |
| NCT02181478 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Myelodysplastic Syndromes|Myelofibrosis|Relapsed Non-Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Hodgkin Lymphoma|Refractory Hodgkin Lymphoma|Relapsed Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia|Lymphoid Malignancies|Chronic Myelogenous Leukemia | 2015-07-22 | EARLY_PHASE1 |
| NCT01292226 | Hoffmann-La Roche | Kidney Transplantation | 2006-12 | PHASE2 |
| NCT00282347 | Genentech, Inc. | Lupus Nephritis | 2006-01 | PHASE3 |
| NCT02029638 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Kidney Transplantation | 2014-01-07 | PHASE2 |
| NCT01499355 | Biogen | Lupus Nephritis | 2012-07 | PHASE2 |
| NCT03415750 | Edoardo Melilli | Hypertrophy, Left Ventricular | 2016-11 | PHASE4 |
| NCT00085449 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2006-05 | PHASE1|PHASE2 |
| NCT07340463 | Nanjing University School of Medicine | Systemic Lupus Erythematosus (SLE)|Lupus Nephritis (LN) | 2025-12-08 | PHASE2 |
| NCT06568549 | Mayo Clinic|Transplant Genomics, Inc.|Eurofins | Kidney Transplantation|Mycophenolate Mofetil | 2025-06-13 | PHASE4 |
| NCT02447055 | Washington University School of Medicine | Multiple Myeloma|Myeloma-Multiple | 2015-12 | EARLY_PHASE1 |
| NCT02809079 | Third Affiliated Hospital, Sun Yat-Sen University|Zhongshan Ophthalmic Center, Sun Yat-sen University|Southern Medical University, China | Neuromyelitis Optica Spectrum Disorders|Mycophenolate Mofetil|Efficacy and Safety | 2016-01 | PHASE4 |
| NCT02005562 | Hoffmann-La Roche | Kidney Transplantation | 2006-05 | PHASE3 |
| NCT00737659 | Rabin Medical Center | Renal Transplant | 2008-08 | PHASE4 |
| NCT00040846 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Peripheral T-cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Progressive Hairy Cell Leukemia, Initial Treatment|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Splenic Marginal Zone Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Mycosis Fungoides+Sezary Syndrome|Stage I Small Lymphocytic Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Mycosis Fungoides+Sezary Syndrome|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Mycosis Fungoides+Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides+Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Waldenstr?m Macroglobulinemia | 2001-11 | PHASE2 |
| NCT00029380 | National Heart, Lung, and Blood Institute (NHLBI) | Hematologic Diseases|Anemia, Sickle Cell|Beta-Thalassemia|Hematopoietic Stem Cell Transplantation | 1999-01 | PHASE2 |
| NCT00014235 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Acute Myeloid Leukemia+Transient Myeloproliferative Disorder|Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Plasmacytoid Dendritic Cell Neoplasm|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK+T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Juvenile Myelomonocytic Leukemia|Mast Cell Leukemia|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Systemic Amyloidosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage II Multiple Myeloma|Stage III Multiple Myeloma|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies|Waldenstr?m Macroglobulinemia | 2000-12 | NA |
| NCT00262886 | University of Rochester | Kidney Cancer | 2001-08 | PHASE2 |
| NCT00301613 | Nanjing University School of Medicine | Henoch-Schoenlein Purpura|Nephritis | 2003-01 | NA |
| NCT00408213 | Hoffmann-La Roche|Aspreva Pharmaceuticals | Myasthenia Gravis Generalised | 2004-06 | PHASE3 |
| NCT05284942 | Tongji Hospital | Rosai-Dorfman Disease|Langerhans Cell Histiocytosis | 2011-10-01 | PHASE4 |
| NCT02896205 | Post Graduate Institute of Medical Education and Research, Chandigarh | Systemic Sclerosis|Scleroderma|Interstitial Lung Disease | 2016-10 | PHASE3 |
| NCT00433953 | Children´s Hospital Medical Center, Cincinnati | Kidney Transplant | 2007-02 | PHASE1 |
| NCT02248597 | Wake Forest University Health Sciences|National Cancer Institute (NCI) | Graft Versus Host Disease|Hematopoietic+Lymphoid Cancer | 2015-02-25 | PHASE2 |
| NCT00261820 | Wyeth is now a wholly owned subsidiary of Pfizer | Graft Rejection|Kidney Failure|Kidney Transplantation | | PHASE4 |
| NCT00007059 | National Center for Research Resources (NCRR)|University of North Carolina | Graft Versus Host Disease | 1998-06 | NA |
| NCT00816413 | University of Nebraska|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes|Nonmalignant Neoplasm | 2008-09 | PHASE1|PHASE2 |
| NCT02839941 | The First Affiliated Hospital with Nanjing Medical University | Kidney Transplantation | 2016-08 | NA |
| NCT04384692 | Fred Hutchinson Cancer Center | Primary Myelofibrosis|Secondary Myelofibrosis | 2020-12-18 | PHASE2 |
| NCT01570348 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|National Institutes of Health (NIH) | Crohn Disease | 2012-07-17 | PHASE2 |
| NCT03262441 | Fred Hutchinson Cancer Center|University of Washington | Human Immunodeficiency Virus I Infection | 2018-02-12 | PHASE2 |
| NCT04375631 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelomonocytic Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelomonocytic Leukemia|Refractory Mixed Phenotype Acute Leukemia|Refractory Myelodysplastic Syndrome|Refractory Acute Leukemia of Ambiguous Lineage|Refractory Acute Undifferentiated Leukemia | 2020-12-03 | PHASE1 |
| NCT02756572 | University of Washington|National Cancer Institute (NCI) | Blasts 10 Percent or More of Bone Marrow Nucleated Cells|Chronic Myelomonocytic Leukemia-2|High Grade Malignant Neoplasm|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts-2|Myeloid Neoplasm|Previously Treated Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia | 2016-09-22 | PHASE2 |